Jiangsu Nhwa Pharmaceutical Competitors and Similar CompaniesClear all
Jiangsu Nhwa Pharmaceutical's competitors and similar companies include Livzon Pharmaceutical Group, PPD, WuXi Biologics and Qilu Pharmaceutical.
 Jiangsu Nhwa Pharmaceutical Jiangsu Nhwa Pharmaceutical ( 江苏恩华药业) is a company engaged in the production and sales of CNS drugs. |  Livzon Pharmaceutical Group Livzon Pharmaceutical Group (丽珠医药集团股份有限公司, 丽珠医药) is a pharmaceutical company that engages in the development and production of active pharmaceutical ingredients, biological drugs, diagnostic reagents, and other products. |  PPD PPD (Pharmaceutical Product Development) is a company that provides drug development and laboratory solutions. |  WuXi Biologics WuXi Biologics (药明生物) is a company operating as an open-access technology platform for biologics drug development. |  Qilu Pharmaceutical Qilu Pharmaceutical (齐鲁制药) is a company that develops, manufactures, and markets generic drugs and active pharmaceutical ingredients (APIs). | |
Founding Date | Founding Date 1978 | Founding Date 1985 | Founding Date 1985 | Founding Date 2010 | Founding Date 1958 |
Type | Type Public | Type Public | Type Subsidiary | Type Public | Type Private |
Tags | |||||
Locations | Locations Xuzhou Shi, CN HQ | Locations Zhuhai, CN HQ Chengdu, CN Qingyuan, CN Shanghai, CN Shaoguan, CN Shenzhen, CN Zhuhai, CN | Locations Wilmington, US HQ Buenos Aires, AR Melbourne, AU Brussels, BE Zaventem, BE São Paulo, BR São Paulo, BR see more | Locations Wuxi, CN HQ George Town, KY Wuppertal, DE Hong Kong, HK Dundalk, IE Cranbury, US King Of Prussia, US | Locations Jinan Shi, CN HQ Boston, US |
Employees | Employees 5,923 | Employees 9,067 | Employees 24,5842% decrease | Employees 12,575 | Employees 39,0008% increase |
Valuation ($) | Valuation ($) 3.8 b | Valuation ($) 4.2 b | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) ¥5.8b (FY, 2025) | Revenue (est.) ¥11.7b (FY, 2025) | Revenue (est.) $4.7b (FY, 2020) | Revenue (est.) ¥21.8b (FY, 2025) | Revenue (est.) N/A |
Cost of goods | Cost of goods ¥1.6b (FY, 2025) | Cost of goods ¥4.1b (FY, 2025) | Cost of goods $1.7b (FY, 2020) | Cost of goods ¥10b (FY, 2025) | Cost of goods N/A |
Gross profit | Gross profit ¥4.2b (FY, 2025) | Gross profit ¥7.8b (FY, 2025) | Gross profit $3b (FY, 2020) | Gross profit ¥12b (FY, 2025) | Gross profit N/A |
Net income | Net income ¥1.1b (FY, 2025) | Net income ¥2.4b (FY, 2025) | Net income $160.6m (FY, 2020) | Net income ¥5.7b (FY, 2025) | Net income N/A |
Operating ⚠ | |||||
Backlog | Backlog N/A | Backlog N/A | Backlog $9.5b (Q3, 2021) | Backlog $18.5b (H1, 2022) | Backlog N/A |
For sources of this data, please see the company profile
View Company Profiles
Livzon Pharmaceutical Group
HQ
Zhuhai, CN
Employees
9,067
Livzon Pharmaceutical Group (丽珠医药集团股份有限公司, 丽珠医药) is a pharmaceutical company that engages in the development and production of active pharmaceutical ingredients, biological drugs, diagnostic reagents, and other products.
View companyPPD
HQ
Wilmington, US
PPD (Pharmaceutical Product Development) is a company that provides drug development and laboratory solutions.
View companyWuXi Biologics
HQ
Wuxi, CN
Employees
12,575
WuXi Biologics (药明生物) is a company operating as an open-access technology platform for biologics drug development.
View companyQilu Pharmaceutical
HQ
Jinan Shi, CN
Employees
39,000↑ 8% increase
Qilu Pharmaceutical (齐鲁制药) is a company that develops, manufactures, and markets generic drugs and active pharmaceutical ingredients (APIs).
View company